Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents

Simon J. Corbett; John Cosgrave; Gloria Melzi; Rade Babic; Giuseppe G L Biondi-Zoccai; Cosmo Godino; Nuccia Morici; Flavio Airoldi; Iassen Michev; Matteo Montorfano; Giuseppe M. Sangiorgi; Erminio Bonizzoni; Antonio Colombo

doi:10.1093/eurheartj/ehl229

Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents

Simon J. Corbett, John Cosgrave, Gloria Melzi, Rade Babic, Giuseppe G L Biondi-Zoccai, Cosmo Godino, Nuccia Morici, Flavio Airoldi, Iassen Michev, Matteo Montorfano, Giuseppe M. Sangiorgi, Erminio Bonizzoni, Antonio Colombo

Research output: Contribution to journal › Article › peer-review

Abstract

Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P

Original language	English
Pages (from-to)	2330-2337
Number of pages	8
Journal	European Heart Journal
Volume	27
Issue number	19
DOIs	https://doi.org/10.1093/eurheartj/ehl229
Publication status	Published - Oct 2006

Keywords

Paclitaxel
Restenosis
Sirolimus
Stent

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1093/eurheartj/ehl229

Cite this

Corbett, S. J., Cosgrave, J., Melzi, G., Babic, R., Biondi-Zoccai, G. G. L., Godino, C., Morici, N., Airoldi, F., Michev, I., Montorfano, M., Sangiorgi, G. M., Bonizzoni, E., & Colombo, A. (2006). Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. European Heart Journal, 27(19), 2330-2337. https://doi.org/10.1093/eurheartj/ehl229

Corbett, SJ, Cosgrave, J, Melzi, G, Babic, R, Biondi-Zoccai, GGL, Godino, C, Morici, N, Airoldi, F, Michev, I, Montorfano, M, Sangiorgi, GM, Bonizzoni, E & Colombo, A 2006, 'Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents', European Heart Journal, vol. 27, no. 19, pp. 2330-2337. https://doi.org/10.1093/eurheartj/ehl229

@article{25d36d36a5c94318bd900817e7e5bfbf,

title = "Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents",

abstract = "Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P",

keywords = "Paclitaxel, Restenosis, Sirolimus, Stent",

author = "Corbett, {Simon J.} and John Cosgrave and Gloria Melzi and Rade Babic and Biondi-Zoccai, {Giuseppe G L} and Cosmo Godino and Nuccia Morici and Flavio Airoldi and Iassen Michev and Matteo Montorfano and Sangiorgi, {Giuseppe M.} and Erminio Bonizzoni and Antonio Colombo",

year = "2006",

month = oct,

doi = "10.1093/eurheartj/ehl229",

language = "English",

volume = "27",

pages = "2330--2337",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "19",

}

TY - JOUR

T1 - Patterns of restenosis after drug-eluting stent implantation

T2 - Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents

AU - Corbett, Simon J.

AU - Cosgrave, John

AU - Melzi, Gloria

AU - Babic, Rade

AU - Biondi-Zoccai, Giuseppe G L

AU - Godino, Cosmo

AU - Morici, Nuccia

AU - Airoldi, Flavio

AU - Michev, Iassen

AU - Montorfano, Matteo

AU - Sangiorgi, Giuseppe M.

AU - Bonizzoni, Erminio

AU - Colombo, Antonio

PY - 2006/10

Y1 - 2006/10

N2 - Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P

AB - Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P

KW - Paclitaxel

KW - Restenosis

KW - Sirolimus

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=33749027753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749027753&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehl229

DO - 10.1093/eurheartj/ehl229

M3 - Article

C2 - 16952923

AN - SCOPUS:33749027753

VL - 27

SP - 2330

EP - 2337

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 19

ER -

Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this